✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Ipca Laboratories Ltd.

IPCALAB

Market Cap
₹37,305 Cr.
P/E
51.14

Ipca Laboratories Ltd.

About
Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that manufactures and markets various formulations and APIs for different therapeutic segments. With a global pre… Read more
Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that ma… Read more
Low
1061
52W Range
High
1758
  • Ipca Laboratories
  • Glenmark Pharma
  • Ajanta Pharma
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0.81 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
1.03 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
55.08 %
(as of Nov 21)
Historic
Anti-Malarial - Market Share
3.84 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Historic
Blood Related - Market Share
2.09 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Branded Generics

Location Wise Break-Up - Generics

Location Wise Break-Up - API

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Bharat Dynamics Ltd.
    • Elgi Equipments Ltd.
    • Borosil Renewables Ltd.
    • GMM Pfaudler Ltd.
    • Gulshan Polyols Ltd.
    FAQs on Ipca Laboratories Ltd. Business

    IPCA Laboratories Limited is a pharmaceutical company founded in 1949, with a global presence in manufacturing and marketing various formulations and APIs across different therapeutic segments. It is a leading supplier of APIs worldwide.

    Ipca Laboratories major competitors are Glenmark Pharma, Ajanta Pharma, JB Chem & Pharma, Glaxosmithkline Phar, Gland Pharma, Wockhardt, Astrazeneca Pharma I.
    Market Cap of Ipca Laboratories is ₹37,305 Crs.
    While the median market cap of its peers are ₹24,688 Crs.

    Ipca Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Ipca Laboratories is 6.74 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Ipca Laboratories Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material